Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group

K Edmonds, Diana Hull, A Spencer-Shaw, J Koldenhof, M Chrysou, C Boers-Doets, A Molassiotis

Research output: Contribution to journal › Article

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Strategies for assessing and managing the adverse events of sorafenib and other targeted therapies in the treatment of renal cell and hepatocellular carcinoma: Recommendations from a European nursing task group'. Together they form a unique fingerprint.

Medicine & Life Sciences